Next generation sequencing technologies have enabled the transcriptome to be profiled at a previously unprecedented speed and depth. This yielded insights into fundamental transcriptomic processes such as gene transcription, RNA processing, and mRNA splicing.
Introduction

RNA Methylation and the development of transcriptomic techniques to detect their occurrence at nucleotide resolution
Covalent modifications to cellular RNA molecules can occur both on the sugar-phosphate RNA backbone as well as on nucleobases and can include those that occur at internal positions as well as those present on 5' or 3' termini. A few of these such as the m7G cap that is ubiquitously present on the 5' terminus of cellular mRNAs have been well characterised. However it is known that well over a hundred types of modified RNA nucleobases can exist, though the characterisation of these have been hampered largely due to a lack of suitable techniques to detect their sequence-specific occurrence. For example, it had for decades been suspected that internal methyl-6-adenosine (m6A) and methyl-5-cytosine (m5C) base methylations may be a common occurrence on mRNAs in mammalian cells (1), but it was only much more recently that the development of refined transcriptomic approaches allowed these modifications to be comprehensively mapped (2,3,4,5,6) thus greatly aiding efforts to investigate their mechanistic roles (6,7,8,9,10) .
Previous important studies were also critical for setting the stage for the recent flurry of activity in the field. It had been shown that a multiprotein complex, which includes the METTL3 and METTL14 subunits, catalyses the formation of m6A in RNA (11) and that an additional enzyme encoded by the FTO gene can remove these methylation marks (12). The latter finding was particularly exciting as it suggested that these RNA methylation events could be dynamically controlled during the execution of important biological processes. Two seminal studies then appeared simultaneously in the literature describing the use of essentially the same immunoprecipitation-based method to map m6A modifications in the transcriptome (2,3) . The approach consisted of fragmenting cellular RNA into small pieces and then using an antibody specific for the methylated base to immunoprecipitate m6Acontaining fragments. Libraries were then prepared from the purified RNAs for highthroughput sequencing on a Next-Generation-Sequencing (NGS) platform. Although the m6A sites could in reality be located anywhere within the sequenced reads, computational algorithms were used to predict the likely methylation site. Importantly it was also found by both studies that most of the RNA fragments mapped to within close vicinity of the stop codon of mRNAs, although the mechanistic significance of this finding remains to be determined.
An additional study published in 2012 also reported transcriptomic identification of m5C using bisulfite sequencing (4), which had been used previously to detect DNA m5C modifications. The authors optimised the protocol so that RNA could seemingly withstand the harsh chemical conditions of the bisulfite treatment. The analysis revealed widespread occurrence of the modification in several RNA biotypes, including mRNAs as previously predicted by Dubin and Taylor (1975) (1). The integrity of the RNA libraries following bisulfite treatment however could not be fully assessed and the method also does not enrich for modified RNA sites, as in the m6A-immunoproecptitaion protocol, meaning that methylation-site detection and calling was likely sub-optimal. Independent approaches were also clearly necessary and were provided by two studies again appearing fortuitously in quick succession in the literature which described distinct but related cross-linking immunoprecipitation (CLIP)-based techniques for detecting m5C RNA modifications (5,6).
Initially described for the use of detecting protein-RNA interactions, efficient CLIP-based techniques employed UV covalent crosslinking to enable the RNA interaction partners of a protein of interest to be identified with high stringency and at a remarkably high signal to noise ratio (13, 14) . The methylation of m5C RNA is catalysed via a covalent catalytic intermediate between the RNA methylase enzyme and RNA substrate: if these catalytic intermediates could be frozen or 'trapped', they could be immunoprecipitated to detect the RNA methylation sites. Khoddami and Cairns (2013) described their 5-azacytidine-mediated RNA immunoprecipitation (Aza-IP) approach where they employed the cytidine nucleoside analogue 5-azacytidine (5), which becomes incorporated into DNA and RNA during replication and transcription respectively. m5C DNA and RNA methylases will methylate cytosine residues as well as 5-azacytosine residues via a covalent catalytic intermediate, but when they methylate the latter, the resolution of the covalent adduct cannot take place due to the altered chemistry of the nucleobases. Thus cells treated with 5-Azacytidine enabled CLIP-based experiments to be performed where an antibody against an epitope-tagged m5C
RNA methylase was used to immunoprecipitate the frozen catalytic intermediates, enabling identification of the methylation substrates. In CLIP experiments, during the cDNA synthesis step of the library preparation, mutations in the sequence are incorporated as the reverse transcriptase traverses the crosslink site; these crosslink-induced mutation sites (CIMS) are estimated to occur at a frequency of ~8-20% of reverse transcription events, and their presence can be used to pinpoint the crosslink/interaction site (15) . Similarly, in the Aza-IP libraries, it was observed that the sequence reads often also contained CIMS at the crosslink/methylation site and hence these could be used to infer the methylation site at nucleotide resolution (5).
Aza-IP involves altering the physiology of cells by requiring a 12 hour pre-incubation with the cytotoxic agent 5-azacytidine, which is known to lead to hypomethylation of DNA even at low doses, and its effect of the nucleoside analogue following incorporation into different RNA species are not fully characterised but may interfere with RNA translation and metabolism. Further, more than 80% of reverse transcription events are estimated to stall at the protein-RNA crosslink site during cDNA synthesis, rather than reading through the crosslink site (16); in CLIP-based techniques, these truncated cDNAs are lost during NGS library preparation as they lack the terminal adapter sequence required for PCR amplification. This is overcome by the individual-nucleotide resolution crosslinking immunoprecipitation (iCLIP) method, which was developed to enable amplification of such truncated cDNAs (17). In iCLIP, the last nucleotide of the truncated cDNAs can be used to identify the crosslink site with increased efficiency (16,17) . The methylation-iCLIP (miCLIP) technique developed in Hussain et al. 2013a describes a customised version of iCLIP (6) that takes advantage of a mutation within the key cysteine residue of m5C RNA methylases that is required for resolution of catalytic intermediates (18,19,20) (Figure 1 ). Substitution of this catalytic cysteine to alanine led to effective trapping of catalytic intermediates, which enabled to crosslink the methylases to its endogenous RNA targets without the need of photocrosslinking. These crosslinked epitope tagged enzyme-substrate covalent adducts are then immunoprecipitated, the cDNA library is prepared using the iCLIP protocol, and the positions of cDNA truncations identified the m5C methylation sites with nucleotideresolution.
The miCLIP study demonstrated that identified m5C substrates were likely of biological relevance. For example, miCLIP for the NSun2 m5C RNA methylase detected methylation sites at various nucleotide positions within the Vault ncRNAs; these were then confirmed by performing bisulfite sequencing of Vault ncRNA extracted from cells obtained from human patients with NSun2-deficiency syndromes (6). The study also showed that the methylation events mechanistically impacted on the processing of Vault hairpin RNAs into small RNAs with microRNA-like function. Importantly there are six other members of the NSun family of m5C RNA methylases which should also be amenable to miCLIP (Figure 1 ).
Recently, a further iCLIP-based technique was developed in order to identify m6A sites at nucleotide resolution in transcriptomes (21). The technique involves incubation of a m6Aantibody with purified cellular RNA followed by in vitro UV-crosslinking. These crosslinked antibody-RNA complexes are then immunoprecipitated, the cDNA library is prepared using the iCLIP protocol, and the positions of cDNA truncations identified the m6A methylation sites with nucleotide-resolution. The procedure was named m6A-iCLIP and abbreviated to miCLIP. To allow a broader use of this term, we suggest that miCLIP is described as methylation-iCLIP, which can then be applied both for cases where protein-RNA complexes are crosslinked within intact cells (6) or purified RNA (21) in order to identify sites of RNA methylation.
An overview of m5C-iCLIP
The aforementioned work (2,3,4,5,6,21) as well as important studies that have also described novel transcriptomic techniques to detect other types of RNA modifications (22,23,21) have set the stage for 'epitranscriptomics'. This area of research concerns the sequence-context specific characterisation and investigation of RNA modifications in complex transcriptomes (24,25,26). Methylation-iCLIP will continue to play an important role in this fledgling field, and in this chapter we describe the m5C-iCLIP protocol. In classic iCLIP experiments, UV crosslinking is required to introduce covalent crosslinks between proteins and interacting RNAs; this step is omitted from the miCLIP protocol. Instead expression of a point-mutant form of an RNA methylase of interest is required which will lead to RNA substrate trapping; we have previously and are currently performing this using point mutant forms of the NSun family of RNA m5C methylases. Experiments can be performed by transfecting suitable expression vectors into cells which also offers the advantage that an antibody against an epitope tag can be used for immunoprecipitation.
Genome editing methods however, may also potentially be used in order to achieve endogenous expression of the point mutant. Following expression, cells are lysed and the enzyme-substrate covalent adducts are recovered by immunoprecipitation; the use of a good, highly specific antibody is key to the experiment and we generally recommend using an antibody against an epitope tag. A multi-step library preparation procedure is then employed which is designed to enable methylation sites to be determined at nucleotide resolution following sequencing of prepared libraries on an NGS platform. Bioinformatics analysis of recovered data can be performed by using the online PIPE-CLIP tool (27) . As in iCLIP, the primers used for cDNA synthesis during library prep contain a randomised barcode (often referred to as unique molecular identifiers or UMIs), which allow individual cDNAs to be counted during analyses, thus yielding a reliable quantitative estimate of crosslinking efficiencies at each nucleotide. 
Gel purification (Note 8)
1. Centrifuge for 20 min at 20,000xg at 4 °C. Remove the supernatant and add 1 mL 80% ethanol. Repeat centrifugation, remove supernatant and then resuspend the pellet in 6 μL H2O.
2. Add 6 μL 2 × TBE-urea loading buffer to the samples and also to 6 μL DNA size marker. Heat samples at 70 °C for 2 min immediately before loading onto a 6% TBE-urea gel (Life Technologies).
3. Run gel in 1X TBE buffer for 40 min at 180 V until the lower dye is close to the bottom. 4 . Cut off the last lane containing the size marker and incubate it in 20 mL 1X TBE buffer with 2 μL SYBR green II for 10 min. Wash the gel twice with 1XTBE and visualize by UV transillumination. Print the result with 100% scale, and use it as a mask to guide the excision of cDNA bands from the rest of the gel.
5.
Together with the preadenylated L3 adapter sequence, the primer sequence accounts for 52 nt of the cDNA. Cut three bands, at 70-80 nt, 80-150 nt and 150-200 nt and transfer them each to a non-stick RNase free 1.5 mL microtube (Note 9). 6. Add 400 μL TE buffer to the gel piece and crush it into tiny pieces with a 1 mL pipette tip.
7. Transfer to a thermomixer and incubate with shaking at 1100 rpm for 1h at 37 °C. Then place on dry ice for 5 min, and then place back for 1 h at 1100 rpm at 37 °C in the thermomixer.
8. Transfer the liquid portion of the supernatant into a Costar SpinX column into which you have placed two 1 cm glass pre-filters. 9 . Centrifuge at 20,000xg for 1 min at room temperature and transfer the flow-through to a non-stick RNase free 1.5mL microtube.
10. Add 1 μL glycoblue and 40 μL sodium acetate solution and mix. Add 1 mL 100% ethanol, mix again and precipitate at −20 °C overnight.
cDNA circularisation (Note 10)
1. Centrifuge for 20 min at 20,000xg at 4 °C. Remove the supernatant and add 1 mL 80% ethanol. Repeat centrifugation, remove supernatant and then resuspend the pellet in 8 μL ligation mix containing 6.5 μL water, 0.8 μL 10× CircLigase Buffer II, 0.4 μL 50 mM MnCl2, 0.3 μL CircLigase II. Transfer the mix to nuclease-free PCR tubes and incubate for 1 h at 60 °C.
2. Add 30 μL oligonucleotide annealing mix: 26 μL H2O, 3 μL FastDigest Buffer, 1 μL BamHI Cut_oligo and anneal in a thermal cycler using the following program: 95 °C for 2 min; then successive cycles of 20 s, starting from 95 °C and decreasing the temperature by 1 °C each cycle down to 25 °C; then hold at 25 °C.
3. Add 2 μL FastDigest BamHI enzyme and incubate for 30 min at 37 °C, followed by an incubation at 80 °C for 5 min. 4. Add 350 μL TE, 1 μL GlycoBlue, 40 μL sodium acetate solution and mix. Then add 1 mL 100 % ethanol, mix again and precipitate overnight at −20 °C.
PCR amplification and library submission
1. Centrifuge for 20 min at 20,000xg at 4 °C. Remove the supernatant and add 1 mL 80% ethanol. Repeat centrifugation, remove supernatant and then resuspend the pellet in 20 μL H20 and transfer to PCR tube. 10 μL of this will be used in the PCR in the next step and the remainder can be stored at −20 °C for further future use if necessary.
2. Prepare the PCR mix as follows: 10 μL cDNA, 1 μL primer mix of P5Solexa and P3Solexa, 20 μL Accuprime Supermix, 9 μL H2O.
3. Place tube in thermal cycler and run the following program: 94 °C for 2 min, followed by 3. Enzymes that catalyse RNA modification via a two-step catalytic process as described in Figure 1 will be amenable to methylation-iCLIP. Several enzymes have been described which are known to catalyse RNA modifications via a covalent intermediate (28) , however the biochemical mechanisms via which these adducts are resolved are often poorly defined. It is possible that amino acid residues within the catalytic domain are critical for resolution, as is observed in the NSun family of RNA m5C methylases, but these will require identification for each particular enzyme before methylation-iCLIP can be performed. 4. Generally, protein G for mouse antibodies, and protein A for rabbit antibodies is used.
5. RNA digestion conditions will need to be pre-optimised for each protein-RNA complex under study. We initially recommend using a 1:50 dilution of RNaseI for 6. The high RNAse sample is only used in the protocol in order to check for the presence of the desired protein-RNA complex following immunoprecipitation, but is not used to prepare libraries as the RNAs would be too short in length to map uniquely to the genome. The RNAs present in the higher molecular weight smear in the low RNase condition are thus used for library preparation only.
A distinct RT primer (one of Rt1clip to Rt16clip) can be used for each of several
replicates or samples if desired. The barcode on these RT primers (see note 2) will then allow for multiplexing of samples thus enabling the cost of next-generationsequencing to be managed. 8 . Gel purification is necessary to remove residual RT primer and also for size fractionation of cDNAs (see note 9). 9. The band cut at 70-80nt will contain a cDNA insert size of 18-28nt; this band usually consists of a high cDNA complexity, but due to the small size of inserts they do not always map to the genome. If the RNA methylase of interest is suspected to methylate microRNAs, then this band should be included for sequencing. The band cut at 80-150nt will contain insert sizes of 29-98nt with a high cDNA complexity; these cDNAs will also map uniquely to the genome and are the best cDNAs. The band cut at 150nt-200nt will contain insert sizes of 98-148nt but this fraction tends to consist of a limited cDNA complexity.
10. Most cDNA synthesis events will truncate at the crosslink site thus allowing the methylation site to be subsequently determined. In order to achieve PCR amplification of these cDNAs however, ligation of a 5' terminal adapter is required. This is achieved by performing a cDNA circularisation followed by a BamHI digestion of a restriction site originally located within the 3'terminal adapter (step 3). This results in a portion of the 3' adapter now being ligated to the 5'end, thus serving as a PCR priming site.
11. The size of the cDNA insert will be the size of PCR product minus the combined length of the P3/P5Solexa primers and the barcode (128 nt). Thus for example, a band cut at 70-80 nt on the cDNA gel (with 18-28nt cDNA + 52 nt primer) will generate 146-156 nt PCR products. substrate. This complex can then be immunoprecipitated using an antibody against the methylase or an epitope tag, and the trapped RNAs are then amenable to purification under highly stringent conditions. Libraries prepared from recovered RNA substrates are then subjected to high-throughput sequencing. Figure 1 
Figure legend
